Tvardi Therapeutics, Inc. (TVRD)
$1.04-1.89%Close
SELLCRISIS · day 21
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $10M
- Beta
- 0.37
- P/E (TTM)
- -0.37
- Short % float
- 3.69%
- Days to cover
- 1.0
- SI change
- -12.2%
- 1W
- -3.70%
- 1M
- -43.17%
- vs SPY 1W
- -3.57%
- vs SPY 1M
- -45.68%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on TVRD?
- LOPJLB’s latest quantitative signal on Tvardi Therapeutics, Inc. (TVRD) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TVRD in?
- Tvardi Therapeutics, Inc. (TVRD) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Tvardi Therapeutics, Inc. (TVRD) do?
- Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical…